Three novel calreticulin mutations in two Turkish patients

Basit Öğe Kaydı
dc.authoridVeysel Sabri Hançer / 0000-0003-2994-1077en_US
dc.authoridMurat Büyükdoğan / 0000-0001-7948-0235
dc.authorscopusidMurat Büyükdoğan / 35247676100
dc.authorscopusidVeysel Sabri Hançer / 6506533543
dc.authorwosidMurat Büyükdoğan / Y-2855-2018
dc.authorwosidVeysel Sabri Hançer / X-8971-2018
dc.contributor.authorHançer, Veysel Sabri
dc.contributor.authorTokgöz, Huseyin
dc.contributor.authorGüvenç, Serkan
dc.contributor.authorÇalışkan, Ümran
dc.contributor.authorBüyükdoğan, Murat
dc.date.accessioned2020-08-29T20:08:13Z
dc.date.available2020-08-29T20:08:13Z
dc.date.issued2017
dc.departmentİstinye Üniversitesien_US
dc.description.abstractCalreticulin (CALR) mutations were first identified exclusively in JAK2-MPL-negative essential thrombocythemia (ET) and primary myelofibrosis (PMF) at a rate of 60%-88%, accounting for 1/4 to 1/3 of all patients with ET and PMF [1,2,3]. As of today, more than 55 different types of mutations have been reported. The two most common mutations accounting for 85% of mutated cases are either a 52-bp deletion (type 1; c.1099_1150del; L367fs*46; 44%- 53% of cases) or a 5-bp insertion (type 2; c.1154_1155insTTGTC; K385fs*47; 32%-42% of cases). The remaining 15% include various other infrequent mutations that are often unique or found in only a few patients [4,5].en_US
dc.identifier.citationHancer, V. S., Tokgoz, H., Guvenc, S., Caliskan, U., & Buyukdogan, M. (2017). Three Novel Calreticulin Mutations in Two Turkish Patients. TURKISH JOURNAL OF HEMATOLOGY, 34(4), 360–361. https://doi.org/10.4274/tjh.2017.0146en_US
dc.identifier.doi10.4274/tjh.2017.0146en_US
dc.identifier.endpage361en_US
dc.identifier.issn1300-7777en_US
dc.identifier.issn1308-5263en_US
dc.identifier.issue4en_US
dc.identifier.pmid28747287en_US
dc.identifier.scopus2-s2.0-85035074181en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage360en_US
dc.identifier.urihttps://doi.org/10.4274/tjh.2017.0146
dc.identifier.urihttps://hdl.handle.net/20.500.12713/905
dc.identifier.volume34en_US
dc.identifier.wosWOS:000418383400018en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorHançer, Veysel Sabrien_US
dc.institutionauthorBüyükdoğan, Muraten_US
dc.language.isoenen_US
dc.publisherGalenos Yayinciliken_US
dc.relation.ispartofTurkish Journal of Hematologyen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectEssential Thrombocythemiaen_US
dc.subjectPrimary Myelofibrosisen_US
dc.subjectCalreticulinen_US
dc.titleThree novel calreticulin mutations in two Turkish patientsen_US
dc.typeLetteren_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
H100.pdf
Boyut:
273.54 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Dahili Tıp Bilimleri Bölümü Makale Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
Temel Tıp Bilimleri Bölümü Makale Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu